Drug makers on India's BSE index are likely to miss estimates when they report their December-quarter earnings, according to Thomson Reuters StarMine.
* Cipla, * Sun Pharmaceuticals Industries and Dr Reddys Laboratories are likely to miss consensus forecasts, according to StarMine SmartEstimates, which places a greater emphasis on forecasts by top-rated analysts.
The drugmakers are among 11 companies on the BSE index that are yet to report October-December earnings.
Hindalco Industries Ltd may post the biggest earnings disappointment, missing its consensus forecasts by 10 percent as per StarMine SmartEstimates.
The table below shows by how much in percentage terms a listed company is expected to miss wider consensus forecasts, according to StarMine SmartEstimates.
Company | Predicted surprise
Hindalco Industries | -10
Cipla | -8
Sun Pharmaceutical Industries | -2.4
Dr Reddy's Laboratories | -2
Tata Steel | -0.9
Oil and Natural Gas Corp | 0
Tata Power | 0
Coal India | 0.1
State Bank of India | 0.1
Mahindra & Mahindra | 0.1